Evaluation of antihyperglycemic effect of sinapic acid in normal and streptozotocin-induced diabetes in albino rats

Global Journal of Pharmacology

Volumn 5, Issue 1, 2011, Pages 33-39

  Kanchana, Ganesan ^a   Shyni, Wilson Jerine ^a   Rajadurai, Murugan ^a   Periasamy, Rathinasamy ^a  

^a MUTHAYAMMAL COLLEGE OF ARTS AND SCIENCE   (India)

Author keywords

Diabetes; Sinapic acid and insulin; Streptozotocin

Indexed keywords

C PEPTIDE; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEXOKINASE; INSULIN; SINAPIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; INSULIN BLOOD LEVEL; NONHUMAN; ORGAN WEIGHT; PHYSIOLOGICAL PROCESS; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

EID: 79957664687     PISSN: 19920075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. World Health Organization, 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Organization, Department of Non communicable disease surveillance, Geneva, Switzerland.
2. Kristova, V., S. Lisková, S. Sotníková, R. Vojtko and A. Kurtansky, 2008. Sulodexide, Improves Endothelial Dysfunction in Streptozotocin- Induced Diabetes in Rats. Physiol. Res., 5: 491-494.
3. Gandhi, H.R., 2001. Diabetes and coronary artery disease: importance of risk factors. Cardiol. Today, 1: 31-4.
4. Kaiser, N., G. Leibowitz and R. Nesher, 2003. Glucotoxicity and • -cell failure in type 2 diabetes mellitus. J. Pediat. Endocrinol. Metab., 16: 5-22.
5. Vavra, J.J., C. DeBoer, A. Dietz, L.J. Hanka and W.T. Sokolski, (1959/1960). Streptozotocin, a new antibacterial antibiotic. Antibiot. Ann., 7: 230-235.
6. Gu, D., M. Arnush and N. Sarvetnic, 1997. Endocrine/exocrine intermediate cells in Streptozotocin treated Ins-IFNgamma transgenic mice. Pancreas, 15(3): 246-50.
7. Brownlee, M., 1992. Glycation products and the pathogenesis of diabetic complications. Diabetes Care, 15: 1835-1843.
8. Mullarkey, C.J., D. Edelstein and L. Brownlee, 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun., 173: 932-939.
9. Scott, M.D., J.J. Van den Berg, T. Repka, et al. 1993. Effect of excess á-hemoglobin chains on cellular and membrane oxidation in model • -thalassemic erythrocyte. J. Clin. Invest., 91: 1706-1712.
10. Saxena, A.K., P. Srivastava, R.K. Kale and N.Z. Baquer, 1993. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem and Pharmacol., 45: 539-42.
11. West, I.C., 2000. Radicals and oxidative stress in diabetes, Diabetic Medicine, 17:171- 80.
12. Rathod Nanu., I. Raghuveer, H.R. Chitme and Ramesh Chandra, 2008. Antidiabetic Activity of Nyctanthes arbortristis. Pharmacognosy Magazine, 16: 335-340.
13. Nanu Rathod., I. Raghuveer, H.R. Chitme and Ramesh Chandra, 2009. Prevention of high fructose-diet induced Insulin resistance by Nyctanthes arbortristis and Calotropis gigantea in rats. Pharmacognosy Magazine, 19: 58-63.
14. Kameswara, B. Rao and C.H. Appa Rao, 2001. Hypoglycemic and antihyperglycemic activity of Alternifolium (Wt.) Walp. Seed extracts in normal and diabetic rats. Phytomedicine, 8: 88-93.
15. Bors, W., W. Heller, C. Michel and K. Stettmaier, 1996. Flavonoids and polyphenols: chemistry and biology. In: Handbook of Antioxidants (Cadenas E. and Paker L., eds.). Marcel Dekker Inc, New York, pp: 409-466.
16. Pietta, P.G. and P. Simonetti, 1998. Dietary flavonoids and interaction with endogenous antioxidant. Bio. chem. Mol. Biol., 44: 1069-1074.
17. Shahidi, F. and M. Naczk, 2004. Ceials, legumes and nuts. In "Phenolics in Food and Nutra Ceuticals, CRC press, Boca Raton, pp: 17-166.
18. Krygier, K., F. Sosulski and L. Hogge, 1982. Free, esterified and insoluble- bound phenolic acids.2. Composition of phenolic acids in rapeseed flour and hulls. J. Agric. Food Chem., 30: 334-336.
19. Nenadis, N., O. Lazaridou and M. Tsimidou, 2007. Use of reference compounds in antioxidant activity assessment. J. Agric. Food Chem., 55: 5452-5460.
20. Niwa, T., D. Umeyuki, Y. Kata and T. Osawa, 1999. Inhibitory mechanism of sinapic acid aginst peroxynitrite- mediated tyrosine nitration of protein in vitro. FEBS Lett., 459: 43-46.
21. Siddiqui, O., Y. Sun, J.C. Lin and Y.W. Chien, 1987. Facilitated transdermal transport of insulin. J. Pharm. Sci., 76: 341-345.
22. Trinder, P., 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor, Annals of Clinical Biochemistry, 6: 24-25.
23. Tietz, N.W., 1999. Clinical guide to laboratory test. 3rd saunders Co.
24. Samuel, K.M., 1989. Note on clinical lab techniques, M.K.G Iyer and Sons Publishers, Madras, 245-255.
25. Kann, C.R. and A.S. Rosenthal, 1979. Immunologic reactions to insulin, insulin allergy, insulin resistance and autoimmune insulin syndrome, Diabetes Care, 2: 283-295.
26. Brandstrup, M., J.E. Kruk and C. Bruni, 1957. Determination of hexokinase in tissues. J. Gerondol., 12: 166-171.
27. Koide, H. and T. Oda, 1959. Pathological occurrence of glucose phosphatase in serum in liver diseases. Clin. Chem. Acta., 4: 554-561.
28. Gancedo, J.M. and C. Gancedo, 1971. Fructose 1,-6 bisphosphatase, phosphofructokinase and glucose-6- phosphate dehydrogenase. Proceedings of the Society for Experimental Biol. and Med., 106: 607-609.
29. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
30. Pepato, M.T., R.H. Migliorini, A.L. Goldberg and I.C. Kettelhut, 1996. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am. J. Physiol. 271: E340-347.
31. Ghosh, R., B. Mukherjee and M. Chatterjee, 1994. A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res., 25: 165-171.
32. Jeffreson, L.S., W.S.T. Liao., D.E. Peavy., J.B. Miller., M.C. Appel and J.M. Jaylor, 1983. Diabetes induced ineractions in liver protein synthesis. Changes in relative abundance of mRNAs for albumin and other plasma proteins. J. Biol. Chem., 258: 1369-1375.
33. Sayer-Hansen, K., 1997. Renal hypertrophy in experimental diabetes relation to severity of diabetes. Diabetologia, 13: 141-143.
34. Yamamoto, H., Y. Uchigata and H. Okamoto, 1981. Sterptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature, 294: 284-286.
35. Doda, R.F., 1996. Diabetes mellitus, In: Kaplan LA, Amadeo JP, eds. Clinical Chemistry. St Louis; Mosby Year Book, 613-41.
36. Schein, P.S., D.A. Cooney, M.G. McMenamin and T. Anderson, 1973. Streptozotocin diabetes-further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem. Pharmacol., 22: 2625-2631.
37. Sen, S., M. Kar, A. Roy and A.S. Chakraborti, 2005. Effect of nonenzymatic gly cation on functional and structural properties of hemoglobin. Biophys. Chem., 113: 289-298.
38. Kumar, P.A., A. Haseeb, P. Suryanarayana, N.Z. Ehtesham and G.B. Reddy, 2005. Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced diabetic rat. Arch. Biochem. Biophys., 444: 77-83.
39. Sheela, C.G. and K.T. Augusti, 1992. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic allium sativum Linn. Indian J. Exp. Biol., 30: 523-526.
40. Haller, M.J., M.S. Stalvey and J.M. Silverstein, 2004. Pedictors of control of diabetes: monitoring may be the key. J. Pediatr, 144: 660-661.
41. Laakso, M., M. Malkki and S.S. Deeb, 1995. Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes, 44: 330-334.
42. O'Doherty, R.M., D.L. Lehman, S. Telemaque-Potts and C.B. Newgard, 1999. Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes, 48: 2022-2027.
43. Ragavan, B. and S. Krishnakumari, 2006. Antidiabetic effect of Terminalia arjuna bark extract in alloxan-induced diabetic rats. Indian J. Clin. Biochem., 21: 123-128.
44. Gupta, D., J. Raju, S. Prakash and N.Z. Baque, 1999. Change in the lipid profile, lipogenic and related enzymes in the liver of experimental diabetic rats: Effect of insulin and vanadate Diabetes res. Clin. Pract., 46: 1-7.
45. Roden, M. and E. Bernroider, 2003. Hepatic glucose metabolism in humans-its role in health and disease. Best Practice Res. Clin. Endocrinol. Metab., 17: 365-383.
46. Pilkis, S.J. and T.H. Claus, 1991. Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu. Rev. Nutr., 11: 465-515.